Report : North America Neurological Biomarkers Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product (Proteomics Biomarker, Genomics Biomarker, Metabolomics Biomarker, Imaging Biomarker, Others); Application (Alzheimer's Disease, Parkinson's Disease, Schizophrenia, Huntington's Disease, Spinal Muscular Atrophy, Others); End User (Pharmaceutical and Biotechnology Companies, Clinical Diagnostics, Research Organizations), and Country

The Genomic Biomarkers Segment Held Largest Share of North America Neurological Biomarkers Market in 2019

 

According to a new market research study of ‘North America Neurological Biomarkers Market to 2027 – Regional Analysis and Forecasts by Product, Application, and End User,’ the North America neurological biomarkers market is expected to reach US$ 2,618.68 Mn in 2027 from US$ 7,056.76 Mn in 2019. The market is estimated to grow with a CAGR of 13.4% from 2020-2027.  The report provides trends prevailing in the North America neurological biomarkers market and the factors driving market along with those that act as hindrances.

 

Based on product, in 2019, the genomic biomarkers segment held the largest share of the market and is expected to grow at the fastest CAGR during the forecast period. This segment is likely to witness a lucrative growth owing to increasing awareness among consumers regarding benefits of genetic medicines as well as technological advancements in the field of neurological biomarkers. In addition, the trend shift towards adoption of gene counseling and genetic analysis for diagnostic purposes is also likely to augment the growth of the segment. The genetic biomarkers are significant modalities that directs towards a more personalized approach of predispositions and medical analysis.

 

Factors such as growing prevalence of neurological disorders and increasing focus toward research in neurological biomarker are expected to fuel the growth of the market. However, the limitation of neurological biomarkers is a major factor hindering the market growth.

 

Thermo Fisher Scientific Inc., Abbott, Bio-Rad Laboratories, Inc., Banyan Biomarkers, Inc, Quest Diagnostics Incorporated, and Perkin Elmer, Inc. are some of the leading companies operating in the North America neurological biomarkers market.

North America Neurological Biomarkers Market, By Regions, 2019 (%)

North America Neurological Biomarkers Market, By Regions, 2019 (%)

 

The report segments North America Neurological Biomarkers Market as follows:

 

North America Neurological Biomarkers Market – By Product

  • Proteomics Biomarker
  • Genomics Biomarker
  • Metabolomics Biomarker
  • Imaging Biomarker
  • Others

North America Neurological Biomarkers Market – By Application

  • Alzheimer’s Disease
  • Parkinson's Disease
  • Schizophrenia
  • Huntington's Disease
  • Spinal Muscular Atrophy
  • Others

North America Neurological Biomarkers Market – By End User

  • Pharmaceutical and Biotechnology Companies
  • Clinical Diagnostics
  • Research Organizations

North America Neurological Biomarkers Market– By Geography

  • North America
    • US
    • Canada
    • Mexico
Contact Us
Contact Person: Sameer Joshi 
Phone: +1-646-491-9876
Email Id: sales@businessmarketinsights.com    

Download Free PDF Brochure